The Real-world Treatment Satisfaction by Gefapixiant in RCC

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 4, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions

Chronic Cough

Interventions

DRUG

Gefapixant Citrate

An additional treatment of gefapixiant will be performed for 12 weeks.

Trial Locations (2)

RECRUITING

Nagoya City University Hospital, Nagoya

NOT_YET_RECRUITING

Nagoya City University, Nagoya

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Nagoya City University

OTHER

NCT06542484 - The Real-world Treatment Satisfaction by Gefapixiant in RCC | Biotech Hunter | Biotech Hunter